Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapyAkira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.International Journal of Cancer|July 18, 2009
Frequency of and variables associated with the EGFR mutation and its subtypesTomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, et al.Contact Dermatitis|April 21, 2017
A multi-institutional joint study of contact dermatitis related to hair colouring and perming agents in JapanAkiko Ito, Kazue Nishioka, Hiromi Kanto, et al.Oncology Reports|January 19, 2008
E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinibAkihiko Miyanaga, Akihiko Gemma, Masahiro Ando, et al.Cancer Science|February 15, 2008
Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutationHitoshi Miyazawa, Tomoaki Tanaka, Yoshiaki Nagai, et al.Contact Dermatitis|December 18, 2021
Patch testing with the Japanese baseline series 2015: A 4-year experienceAkiko Ito, Kayoko Suzuki, Kayoko Matsunaga, et al.Plos One|September 13, 2011
Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesisTakashi Hirama, Takefumi Yamaguchi, Hitoshi Miyazawa, et al.Contact Dermatitis|March 4, 2021
Multicenter 1-month follow-up study of the patch-test reaction to the gold sodium thiosulfate of the TRUE Test and its association with piercings and dental metal historyKayoko Suzuki, Kayoko Matsunaga, Akiko Ito, et al.The New England Journal of Medicine|June 25, 2010
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRMakoto Maemondo, Akira Inoue, Kunihiko Kobayashi, et al.American Journal of Respiratory and Critical Care Medicine|November 11, 2006
Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasisHuqun, Shinyu Izumi, Hitoshi Miyazawa, et al.Pageof 3